Phosphatidylinositol 3-Kinase Signaling Controls Levels of Hypoxia-Inducible Factor 1.

BH Jiang,GQ Jiang,JZ Zheng,ZM Lu,T Hunter,PK Vogt

2001-01-01

Abstract:The phosphatidylinositol 3-kinase (PI3K) signaling pathway has inherent oncogenic potential. It is upregulated in diverse human cancers by either a gain of function in PI3K itself or in its downstream target Akt or by a loss of function in the negative regulator PTEN, However, the complete consequences of this upregulation are not known. Here we show that insulin and epidermal growth factor or an inactivating mutation in the tumor suppressor PTEN specifically increase the protein levels of hypoxia-inducible factor (HIF) 1 alpha but not of HIF-1 beta in human cancer cell lines. This specific elevation of HIF-1 alpha protein expression requires PI3K signaling. In the prostate carcinoma-derived cell lines PC-3 and DU145, insulin- and epidermal growth factor-induced expression of HIF-1 alpha was inhibited by the PI3K-specific inhibitors LY294002 and wortmannin in a dose-dependent manner. HIF-1 beta expression was not affected by these inhibitors. Introduction of wild-type PTEN into the PTEN-negative PC-3 cell line specifically inhibited the expression of HIF-1 alpha but not that of HIF-1 beta, In contrast to the HIF-1 alpha protein, the level of HIF-1 alpha mRNA was not significantly affected by PI3K signaling. Vascular endothelial growth factor reporter gene activity was induced by insulin in PC-3 cells and was inhibited by the PI3K inhibitor LY294002 and by the coexpression of a HIF-1 dominant negative construct. Vascular endothelial growth factor reporter gene activity was also inhibited by expression of a dominant negative PI3K construct and by the tumor suppressor PTEN.